Lemborexant
| CAS No. | 1369764-02-2 | Cat. No. | BCP16633 |
| Name | Lemborexant | ||
| Synonyms | E 2006;E-2006;E2006; | ||
| Formula | C22H20F2N4O2 | M. Wt | 410.42 |
| Description | Lemborexant, also known as E-2006, is a dual antagonist of the orexin OX1 and OX2 receptors which is under development by Eisai for the treatment of insomnia. As of December 2014, it is in phase II clinical trials. | ||
| Pathways | GPCR/G Protein | ||
| Targets | OX Receptor | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.